{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:07:58Z","timestamp":1760148478736,"version":"build-2065373602"},"reference-count":38,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cFunda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo\u2014FAPESP\u201d","award":["2018\/11624-9","12\/16710-4","10\/50439-0"],"award-info":[{"award-number":["2018\/11624-9","12\/16710-4","10\/50439-0"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico\u2014CNPq","award":["2018\/11624-9","12\/16710-4","10\/50439-0"],"award-info":[{"award-number":["2018\/11624-9","12\/16710-4","10\/50439-0"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Paracoccidioidomycosis (PCM) is a systemic mycosis caused by Paracoccidioides brasiliensis, a thermally dimorphic fungus, which is the most frequent endemic systemic mycosis in many Latin American countries, where ~10 million people are believed to be infected. In Brazil, it is ranked as the tenth most common cause of death among chronic infectious diseases. Hence, vaccines are in development to combat this insidious pathogen. It is likely that effective vaccines will need to elicit strong T cell-mediated immune responses composed of IFN\u03b3 secreting CD4+ helper and CD8+ cytolytic T lymphocytes. To induce such responses, it would be valuable to harness the dendritic cell (DC) system of antigen-presenting cells. To assess the potential of targeting P10, which is a peptide derived from gp43 secreted by the fungus, directly to DCs, we cloned the P10 sequence in fusion with a monoclonal antibody to the DEC205 receptor, an endocytic receptor that is abundant on DCs in lymphoid tissues. We verified that a single injection of the \u03b1DEC\/P10 antibody caused DCs to produce a large amount of IFN\u03b3. Administration of the chimeric antibody to mice resulted in a significant increase in the levels of IFN-\u03b3 and IL-4 in lung tissue relative to control animals. In therapeutic assays, mice pretreated with \u03b1DEC\/P10 had significantly lower fungal burdens compared to control infected mice, and the architecture of the pulmonary tissues of \u03b1DEC\/P10 chimera-treated mice was largely normal. Altogether, the results obtained so far indicate that targeting P10 through a \u03b1DEC\/P10 chimeric antibody in the presence of polyriboinosinic: polyribocytidylic acid is a promising strategy in vaccination and therapeutic protocols to combat PCM.<\/jats:p>","DOI":"10.3390\/jof9050548","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T03:49:06Z","timestamp":1683690546000},"page":"548","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the P10 Peptide in Maturing Dendritic Cells via the DEC205 Receptor In Vivo: A New Therapeutic Strategy against Paracoccidioidomycosis"],"prefix":"10.3390","volume":"9","author":[{"given":"Suelen S.","family":"Santos","sequence":"first","affiliation":[{"name":"Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences, University of S\u00e3o Paulo, S\u00e3o Paulo 05508-000, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eline","family":"Rampazo","sequence":"additional","affiliation":[{"name":"Department of Parasitology, Biomedical Sciences Institute, University of S\u00e3o Paulo, S\u00e3o Paulo 05508-000, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9928-9809","authenticated-orcid":false,"given":"Carlos P.","family":"Taborda","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Biomedical Sciences Institute, University of S\u00e3o Paulo, S\u00e3o Paulo 05508-000, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Nosanchuk","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Division of Infectious Diseases, Microbiology and Immunology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10461, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7845-7110","authenticated-orcid":false,"given":"Silvia B.","family":"Boscardin","sequence":"additional","affiliation":[{"name":"Department of Parasitology, Biomedical Sciences Institute, University of S\u00e3o Paulo, S\u00e3o Paulo 05508-000, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0562-1610","authenticated-orcid":false,"given":"Sandro R.","family":"Almeida","sequence":"additional","affiliation":[{"name":"Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences, University of S\u00e3o Paulo, S\u00e3o Paulo 05508-000, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fimmu.2016.00063","article-title":"Antibody Targeting of \u201cSteady-State\u201d Dendritic Cells Induces Tolerance Mediated by Regulatory T Cells","volume":"7","author":"Mahnke","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1084\/jem.20052545","article-title":"Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection","volume":"203","author":"Khader","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1078\/0171-2985-00105","article-title":"Dendritic cell-based vaccination strategies: Induction of protective immunity against leishmaniasis","volume":"204","author":"Moll","year":"2001","journal-title":"Immunobiology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.194.6.769","article-title":"Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo","volume":"194","author":"Hawiger","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1084\/jem.20021598","article-title":"Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance","volume":"196","author":"Bonifaz","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1084\/jem.20051639","article-title":"Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses","volume":"203","author":"Boscardin","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.20052005","article-title":"Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine","volume":"203","author":"Trumpfheller","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1084\/jem.20032220","article-title":"In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination","volume":"199","author":"Bonifaz","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1073\/pnas.0711976105","article-title":"The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine","volume":"105","author":"Trumpfheller","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_10","first-page":"785","article-title":"Epidemiology of endemic systemic fungal infections in Latin America","volume":"49","author":"Colombo","year":"2011","journal-title":"Med. Mycol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.fgb.2017.05.007","article-title":"Species boundaries in the human pathogen Paracoccidioides","volume":"106","author":"Turissini","year":"2017","journal-title":"Fungal. Genet. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/mmy.39.3.233.241","article-title":"The habitat of Paracoccidioides brasiliensis: How far from solving the riddle?","volume":"39","author":"Restrepo","year":"2001","journal-title":"Med. Mycol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.femsim.2005.05.013","article-title":"Functional genome of the human pathogenic fungus Paracoccidioides brasiliensis","volume":"45","author":"Felipe","year":"2005","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2217\/fmb.13.68","article-title":"Paracoccidioidomycosis: Eco-epidemiology, taxonomy and clinical and therapeutic issues","volume":"8","author":"Bocca","year":"2013","journal-title":"Fut. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1128\/jcm.29.8.1610-1615.1991","article-title":"43-kilodalton glycoprotein from Paracoccidioides brasiliensis: Immunochemical reactions with sera from patients with paracoccidioidomycosis, histoplasmosis, or Jorge Lobo\u2019s disease","volume":"29","author":"Puccia","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1128\/IAI.66.2.786-793.1998","article-title":"Mapping of the T-cell epitope in the major 43-kilodalton glycoprotein of Paracoccidioides brasiliensis which induces a Th-1 response protective against fungal infection in BALB\/c mice","volume":"66","author":"Taborda","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1128\/AAC.00220-06","article-title":"Peptide immunization as an adjuvant to chemotherapy in mice challenged intratracheally with virulent yeast cells of Paracoccidioides brasiliensis","volume":"50","author":"Marques","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.micinf.2008.07.027","article-title":"Additive effect of P10 immunization and chemotherapy in anergic mice challenged intratracheally with virulent yeasts of Paracoccidioides brasiliensis","volume":"10","author":"Marques","year":"2008","journal-title":"Microbes Infect."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1476-5381.2009.00617.x","article-title":"Poly(lactic acid-glycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis","volume":"159","author":"Amaral","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1128\/IAI.01470-08","article-title":"Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin","volume":"77","author":"Braga","year":"2009","journal-title":"Infect. Immun."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Rittner, G.M., Munoz, J.E., Marques, A.F., Nosanchuk, J.D., Taborda, C.P., and Travassos, L.R. (2012). Therapeutic DNA vaccine encoding peptide P10 against experimental paracoccidioidomycosis. PLoS Negl. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001519"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.micinf.2012.11.007","article-title":"DNA vaccine encoding peptide P10 against experimental paracoccidioidomycosis induces long-term protection in presence of regulatory T cells","volume":"15","author":"Magalhaes","year":"2013","journal-title":"Microbes Infect."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4049\/jimmunol.159.2.565","article-title":"Dendritic cell subtypes in mouse lymphoid organs: Cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes","volume":"159","author":"Vremec","year":"1997","journal-title":"J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Matos, I., Mizenina, O., Lubkin, A., Steinman, R.M., and Idoyaga, J. (2013). Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity. PLoS ONE, 8.","DOI":"10.1371\/annotation\/5149bf8e-3843-4865-a726-0ca2820ee8f8"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1002\/eji.201040511","article-title":"Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague","volume":"40","author":"Do","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.1136080","article-title":"Differential antigen processing by dendritic cell subsets in vivo","volume":"315","author":"Dudziak","year":"2007","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Henriques, H.R., Rampazo, E.V., Goncalves, A.J., Vicentin, E.C., Amorim, J.H., Panatieri, R.H., Amorim, K.N., Yamamoto, M.M., Ferreira, L.C., and Alves, A.M. (2013). Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002330"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1073\/pnas.92.16.7297","article-title":"A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine","volume":"92","author":"Boussif","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1590\/S0365-05962011000300014","article-title":"Immunology of paracoccidioidomycosis","volume":"86","author":"Fortes","year":"2011","journal-title":"An. Bras. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Araujo, M.V., Santos Junior, S.R.D., Nosanchuk, J.D., and Taborda, C.P. (2020). Therapeutic Vaccination with Cationic Liposomes Formulated with Dioctadecyldimethylammonium and Trehalose Dibehenate (CAF01) and Peptide P10 Is Protective in Mice Infected with Paracoccidioides brasiliensis. J. Fungi, 6.","DOI":"10.3390\/jof6040347"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fcimb.2020.00463","article-title":"Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections","volume":"10","author":"Kischkel","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"670992","DOI":"10.3389\/fimmu.2021.670992","article-title":"Identification of Potentially Therapeutic Immunogenic Peptides From Paracoccidioides lutzii Species","volume":"12","author":"Silva","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fmicb.2012.00212","article-title":"New advances in the development of a vaccine against paracoccidioidomycosis","volume":"3","author":"Travassos","year":"2012","journal-title":"Front. Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.abd.2020.07.011","article-title":"Disseminated paracoccidioidomycosis in a liver transplant patient","volume":"96","author":"Valentim","year":"2021","journal-title":"An. Bras. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1128\/IAI.72.7.3932-3940.2004","article-title":"Dual role of interleukin-4 (IL-4) in pulmonary paracoccidioidomycosis: Endogenous IL-4 can induce protection or exacerbation of disease depending on the host genetic pattern","volume":"72","author":"Arruda","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3389\/fmicb.2017.01057","article-title":"Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis","volume":"8","author":"Silva","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"232ra251","DOI":"10.1126\/scitranslmed.3008068","article-title":"Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205","volume":"6","author":"Dhodapkar","year":"2014","journal-title":"Sci. Transl. Med."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/9\/5\/548\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:31:51Z","timestamp":1760124711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/9\/5\/548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,10]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["jof9050548"],"URL":"https:\/\/doi.org\/10.3390\/jof9050548","relation":{},"ISSN":["2309-608X"],"issn-type":[{"type":"electronic","value":"2309-608X"}],"subject":[],"published":{"date-parts":[[2023,5,10]]}}}